Publication date: Available online 31 October 2026 Source: Clinical Breast Cancer Author(s): Maysa Coelho Vieira-Costa, Leandro Teodoro Júnior, Mari Cleide Sogayar
Triple-Negative Breast Cancer heterogeneity: extracellular matrix, immune evasion, and therapeutic resistance landscape. // Clinical Breast Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S1526820926001928?dgcid=rss_sd_all
Triple-Negative Breast Cancer heterogeneity: extracellular matrix, immune evasion, and therapeutic resistance landscape. Clinical Breast Cancer. https://www.sciencedirect.com/science/article/pii/S1526820926001928?dgcid=rss_sd_all
“Triple-Negative Breast Cancer heterogeneity: extracellular matrix, immune evasion, and therapeutic resistance landscape.” Clinical Breast Cancer.
@article{article40689,
title = {Triple-Negative Breast Cancer heterogeneity: extracellular matrix, immune evasion, and therapeutic resistance landscape},
journal = {Clinical Breast Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S1526820926001928?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment